azides has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambudkar, SV; Limtrakul, P; Ohnuma, S; Pintha, K; Pitchakarn, P; Pompimon, W | 1 |
| Carlino, JA; Creasey, AA; Lin, LS | 1 |
2 other study(ies) available for azides and Cancer of Cervix
| Article | Year |
|---|---|
Kuguacin J isolated from Momordica charantia leaves inhibits P-glycoprotein (ABCB1)-mediated multidrug resistance.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Binding Sites; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Fluoresceins; Humans; Molecular Structure; Momordica charantia; Paclitaxel; Plant Leaves; Prazosin; Rhodamine 123; Triterpenes; Uterine Cervical Neoplasms; Vinblastine | 2012 |
Use of a sensitive receptor binding assay to discriminate between full-length and truncated human recombinant tumor necrosis factor proteins.
Topics: Amino Acid Sequence; Azides; Binding, Competitive; Cell Line; Cell Membrane; Female; Glycoproteins; Humans; Kinetics; Peptide Fragments; Radioligand Assay; Recombinant Proteins; Sodium Azide; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 1987 |